FindTrial
Sign In

Self monitoring of blood glucose

DEVICE5 trials

Sponsors

Imperial College London, Abbott Diabetes Care, Institut de Recherche pour la Sante et Developpement, Foundation for Innovative New Diagnostics, Specialized Medicine Hospital

Conditions

Autoimmune DiseasesDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Endocrine System DiseasesGlucose Metabolism DisordersMetabolic DiseaseNutritional, Metabolic, Endocrine

Phase 4

Using Flash Glucose Monitoring Intermittently to Help People with Type 1 Diabetes in Developing Countries
Active, not recruitingPACTR202508773048652
Specialized Medicine HospitalNutritional, Metabolic, Endocrine
Start: 2024-07-01Target: 90Updated: 2026-01-27

Unknown Phase

RT-CGM in Young Adults at Risk of DKA
RecruitingNCT04039763
Imperial College LondonAutoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1 +3
Start: 2020-09-03End: 2022-06-30Target: 20Updated: 2022-06-24
Effects of optimisation of glycaemic control on early remission in type 2 diabetes
Active, not recruitingPACTR202009815264860
Institut de Recherche pour la Sante et DeveloppementNutritional, Metabolic, Endocrine
Start: 2016-10-03Target: 10Updated: 2026-01-27
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
Active, not recruitingNCT05944432
Abbott Diabetes CareDiabetes Mellitus, Type 2
Start: 2023-07-14End: 2027-11-30Target: 470Updated: 2026-02-12
Use of continuous glucose monitoring devices among people living with type 1 diabetes in Kenya.
Active, not recruitingPACTR202309743823347
Foundation for Innovative New DiagnosticsNutritional, Metabolic, Endocrine
Start: 2023-09-04Target: 246Updated: 2026-01-27

Related Papers

Impact of real-time glucose monitoring using FreeStyle Libre 3 on glycaemia in type 2 diabetes managed with basal insulin plus SGLT2 inhibitor and/or GLP-1 agonist: the FreeDM2 randomised controlled trial protocol
BMJ Open2025-04-01